Stereotactic Radiosurgery in the Treatment of Essential Tremor
Key facts
- Phase
- Phase 2
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Maria Sklodowska-Curie National Research Institute of Oncology
- Trial code
- NCT06821906
- Record updated
- 20 October 2026
- Original description
The goal of this interventional study is to evaluate the effectiveness of treatment using stereotactic radiosurgery in the treatment of essential tremor in adult patientsRead full original descriptionShow less
Stereotactic Radiosurgery in the Treatment of Tremor in Patients With Essential Tremor - a Randomized Phase II Study
The goal of this interventional study is to evaluate the effectiveness of treatment using stereotactic radiosurgery in the treatment of essential tremor in adult patients
Inclusion: Essential tremor diagnosed, Parkinson's disease and other causes of tremor excluded; Insufficient tremor control despite the use of available pharmacotherapy methods; Disqualification from the Deeply Brain Stimualtion procedure/lack of consent to perform it on the side qualified for Stereotactic Radiosurgery; Consent to participate in a clinical trial.
Exclusion: Previous radiotherapy to the brain covering the potential treatment area; Duration of the disease less than 5 years; Dementia, psychosis or other condition that prevents giving informed consent to participate in the study; Poor general condition, serious comorbidities; Age under 50; Pregnancy; Structural changes in the basal ganglia or major atrophic changes; Medical contraindications to magnetic resonance imaging.